Jumonji domain containing 3 (JMJD3; KDM6B); lysine-specific demethylase 6A (KDM6A; UTX) BriefCommunication Pages: 809 - 809
Chemokine CXC motif ligand 1 (CXCL1; GRO; MGSA); CXCL2 (MIP2); CXC chemokine receptor 2 (CXCR2; IL8RB) BriefCommunication Pages: 810 - 810
Mammalian target of rapamycin complex 1 (mTORC1); lamin A/C (LMNA) BriefCommunication Pages: 813 - 813
Phospholipase A2 group IVA cytosolic calcium-dependent (PLA2G4A; cPLA2-α) BriefCommunication Pages: 816 - 816
β-Site APP-cleaving enzyme 1 (BACE1); amyloid precursor protein (APP) BriefCommunication Pages: 819 - 819
Impact of receptor tyrosine kinase (RTK) ligands on sensitivity of human tumor–derived cell lines to kinase inhibitors BriefCommunication Pages: 825 - 825
Stromal and cancer cell coculture system to uncover drug resistance mechanisms and guide combination therapy BriefCommunication Pages: 826 - 826
Intracellular delivery of therapeutic small interfering RNA with carbonate co-oligomers BriefCommunication Pages: 827 - 827
Systemic delivery of antisense oligonucleotide therapy for myotonic dystrophy type 1 (DM1) BriefCommunication Pages: 829 - 829